David Esrig
Impact in
Papers in
- Co-authors
- Donald G. Skinner (43 shared papers)John P. Stein (40 shared papers)John A. Freeman (32 shared papers)Richard J. Côté (22 shared papers)Susan Groshen (18 shared papers)Peter W. Nichols (7 shared papers)Donald A. Elmajian (16 shared papers)Gary Lieskovsky (27 shared papers)
- Journals
- The Journal of Urology (30 papers)Urology (8 papers)JNCI Journal of the National Cancer Institute (2 papers)World Journal of Urology (2 papers)Journal of Clinical Oncology (1 paper)
- Partner nations
- United StatesAustriaDenmark
In The Last Decade
David Esrig
56 papers receiving 4.0k citations
David Esrig's Hit Papers
Peers
Comparison fields: 5 of 81
- Urology 1.1k
- Surgery 3.1k
- Biotechnology 350
- Cancer Research 596
- Oncology 1.0k
Countries citing papers authored by David Esrig
This map shows the geographic impact of David Esrig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Esrig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Esrig more than expected).
Fields of papers citing papers by David Esrig
This network shows the impact of papers produced by David Esrig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Esrig. The network helps show where David Esrig may publish in the future.
Co-authors
The 25 scholars most cited alongside David Esrig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Accumulation of Nuclear p53 and Tumor Progression in Bladder Cancer Hit paper breakdown → | 1994 | 630 |
| 2 | Two molecular pathways to transitional cell carcinoma of the bladder. | 1994 | 475 |
| 3 | p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. | 1993 | 404 |
| 4 | 1997 | 259 | |
| 5 | 1998 | 245 | |
| 6 | 1998 | 231 | |
| 7 | 2011 | 165 | |
| 8 | 1995 | 148 | |
| 9 | 1996 | 142 | |
| 10 | 1996 | 134 | |
| 11 | 1995 | 119 | |
| 12 | 1996 | 116 | |
| 13 | 1995 | 103 | |
| 14 | 1997 | 101 | |
| 15 | 1994 | 99 | |
| 16 | 1994 | 97 | |
| 17 | 1997 | 89 | |
| 18 | 1998 | 79 | |
| 19 | 1996 | 67 | |
| 20 | 1994 | 66 |
About David Esrig
David Esrig is a scholar working on Surgery, Urology, Pulmonary and Respiratory Medicine, Oncology and Rheumatology, having authored 56 papers that have together received 4.2k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (33 papers), Urinary and Genital Oncology Studies (15 papers), Urological Disorders and Treatments (15 papers), Cancer-related Molecular Pathways (7 papers), Prostate Cancer Diagnosis and Treatment (6 papers), Prostate Cancer Treatment and Research (4 papers), Urologic and reproductive health conditions (4 papers) and Cancer Research and Treatments (3 papers). The work is most often cited by research in Urology (1.1k citations), Surgery (3.1k citations), Biotechnology (350 citations), Cancer Research (596 citations) and Oncology (1.0k citations). David Esrig has collaborated with scholars based in United States, Austria and Denmark. Frequent co-authors include Donald G. Skinner, John P. Stein, John A. Freeman, Richard J. Côté, Susan Groshen, Peter W. Nichols, Donald A. Elmajian, Gary Lieskovsky, Peter A. Jones and Gary D. Grossfeld. Their work appears in journals such as The Journal of Urology, Urology, JNCI Journal of the National Cancer Institute, World Journal of Urology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.